242 related articles for article (PubMed ID: 34286445)
1. CCL27 Signaling in the Tumor Microenvironment.
Martínez-Rodríguez M; Monteagudo C
Adv Exp Med Biol; 2021; 1302():113-132. PubMed ID: 34286445
[TBL] [Abstract][Full Text] [Related]
2. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
3. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
4. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
Jeong SI; Lee YE; Jang SI
J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC).
Homey B; Wang W; Soto H; Buchanan ME; Wiesenborn A; Catron D; Müller A; McClanahan TK; Dieu-Nosjean MC; Orozco R; Ruzicka T; Lehmann P; Oldham E; Zlotnik A
J Immunol; 2000 Apr; 164(7):3465-70. PubMed ID: 10725697
[TBL] [Abstract][Full Text] [Related]
6. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
8. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis.
Riis JL; Johansen C; Vestergaard C; Bech R; Kragballe K; Iversen L
Exp Dermatol; 2011 Oct; 20(10):789-94. PubMed ID: 21707761
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
11. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.
Homey B; Alenius H; Müller A; Soto H; Bowman EP; Yuan W; McEvoy L; Lauerma AI; Assmann T; Bünemann E; Lehto M; Wolff H; Yen D; Marxhausen H; To W; Sedgwick J; Ruzicka T; Lehmann P; Zlotnik A
Nat Med; 2002 Feb; 8(2):157-65. PubMed ID: 11821900
[TBL] [Abstract][Full Text] [Related]
12. Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives.
Mergia Terefe E; Catalan Opulencia MJ; Rakhshani A; Ansari MJ; Sergeevna SE; Awadh SA; Polatova DS; Abdulkadhim AH; Mustafa YF; Kzar HH; Al-Gazally ME; Kadhim MM; Taherian G
Expert Rev Mol Med; 2022 Sep; 24():e37. PubMed ID: 36155126
[TBL] [Abstract][Full Text] [Related]
13. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
[TBL] [Abstract][Full Text] [Related]
14. CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
Kagami S; Saeki H; Komine M; Kakinuma T; Nakamura K; Tsunemi Y; Sasaki K; Asahina A; Tamaki K
Exp Dermatol; 2006 Feb; 15(2):95-100. PubMed ID: 16433680
[TBL] [Abstract][Full Text] [Related]
15. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
Moed H; Boorsma DM; Tensen CP; Flier J; Jonker MJ; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Rustemeyer T; Gibbs S
J Pathol; 2004 Sep; 204(1):39-46. PubMed ID: 15307136
[TBL] [Abstract][Full Text] [Related]
16. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
17. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
18. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.
Goteri G; Rupoli S; Campanati A; Zizzi A; Picardi P; Cardelli M; Giantomassi F; Canafoglia L; Marchegiani F; Mozzicafreddo G; Brandozzi G; Stramazzotti D; Ganzetti G; Lisa R; Simonetti O; Offidani A; Federici I; Filosa G; Leoni P
Br J Dermatol; 2012 May; 166(5):948-52. PubMed ID: 22233400
[TBL] [Abstract][Full Text] [Related]
19. Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes.
Karakawa M; Komine M; Tamaki K; Ohtsuki M
Arch Dermatol Res; 2010 Dec; 302(10):763-7. PubMed ID: 20625754
[TBL] [Abstract][Full Text] [Related]
20. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
